Charles River Laboratories International, Inc.

NYSE:CRL

Medical - Diagnostics & Research

Healthcare
$333.25 -1.33%

-$2.45 today

Market cap
$15.97B
Beta
1.45
P/E (TTM)
-48.3
EPS (TTM)
-$3.77
52W Low $144.26High $228.88

Volume 0.52M

Average 0.86M

CRL Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Charles River Laboratories International, Inc.NYSE: CRL

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin widens to 11.9%

Operating margin was 11.9% in Q2 FY2026, up 2.2 pp from a year earlier. On a trailing-twelve-month basis it was 12.3%, up 9.3 pp year over year. Over 3 fiscal years it narrowed by 3.7 pp.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 10 analysts of 23.5% for the fiscal year ending Dec 2026, up from 12.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
11.9%-0.1 pp QoQ
Last fiscal yearDec 2025
12.6%+7.0 pp YoY
LTMJun 2026
12.3%+9.3 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.2 pp+11.0 pp+8.8 pp
1 year+7.0 pp+10.8 pp+3.8 pp
3 years-3.7 pp+13.7 pp+17.4 pp
5 years+15.1 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
12.6%
Year-over-year change
+7.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How CRL compares with its peers on the latest reported figures

  • CRL's LTM Jun 2026 operating margin of 12.3% is the 2nd highest of the 4 companies compared; the peer median is 10.1%.
  • Its year-over-year change of +9.3 pp is the highest of 4, against a peer median of -0.1 pp.
  • Over three fiscal years its change of -3.7 pp compares with a peer median of +2.0 pp.
CRL Competitors Peer median
Operating Margin for CRL and competitors
Company Period LTM level YoY 3-year change
MEDPMedpace Holdings, Inc.LTM Sep 202621.4% -0.1 pp+2.1 pp
CRLCharles River Laboratories International, Inc.LTM Jun 202612.3% +9.3 pp-3.7 pp
ICLRICON Public Limited CompanyLTM Jun 202610.1% -2.4 pp+2.0 pp
CERTCertara, Inc.LTM Mar 20264.1% +2.3 pp-4.7 pp
Peer median (excluding CRL) 10.1%-0.1 pp+2.0 pp

Competitors are the stored peer set for CRL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.54B3.98B4.13B4.05B4.02B
Cost of Revenue2.21B2.51B2.63B2.72B2.79B
Gross Profit1.33B1.46B1.5B1.33B1.23B
Gross Margin37.7%36.8%36.4%32.9%30.5%
Research & Development00000
Selling, General & Admin619.92M665.1M747.86M751M743.07M
Operating Expenses744.78M811.68M885.3M1.1B717.73M
Depreciation & Amortization265.54M303.87M314.12M361.74M403.31M
EBITDA820.16M986.15M1.03B581.14M410.84M
EBITDA Margin23.2%24.8%25.0%14.3%10.2%
Operating Income589.86M650.98M617.26M227.35M507.84M
Operating Margin16.7%16.4%14.9%5.6%12.6%
Interest Income652K780K5.2M8.58M4.94M
Interest Expense73.91M59.29M136.71M126.29M107.03M
Other Income / Expenses(109.15M)(27.99M)(35.98M)(134.23M)(607.34M)
Income Before Tax480.71M622.99M581.28M93.11M(99.5M)
Pre-Tax Margin13.6%15.7%14.1%2.3%-2.5%
Income Tax Expense81.87M130.38M100.91M67.82M42.66M
Net Income390.98M486.23M474.62M10.3M(144.34M)
Net Margin11.0%12.2%11.5%0.3%-3.6%
EPS (Basic)7.779.579.270.20(2.91)
EPS (Diluted)7.609.489.220.20(2.91)
Weighted Avg Shares50.29M50.81M51.23M51.38M49.56M
Weighted Avg Shares (Diluted)51.43M51.3M51.45M51.63M49.56M

Charles River Laboratories International, Inc.

NYSE:CRL

Intrinsic Alpha fair value

Locked

Current Price

$333.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.